Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: An alternative to fluorescent antibody to membrane antigen test

Journal of Virological Methods

Volumn 119, Issue 1, 2004, Pages 25-30

  Sauerbrei, A ^a   Farber I ^a   Brandstadt A ^a   Schacke, M ^a   Wutzler, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Anti varicella zoster virus IgG; Fluorescent antibody to membrane antigen test (FAMA); Immunity; Indirect fluorescence antibody test (IFAT); Varicella zoster virus

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CANCER CELL CULTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; LABORATORY TEST; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS IDENTIFICATION;

ANTIBODIES, VIRAL; ANTIGENS, SURFACE; ANTIGENS, VIRAL; CHICKENPOX; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN HERPESVIRUS 3;

EID: 1942421748     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2004.02.012     Document Type: Article

References (33)

1. Balfour H.H. Jr., Edelman C.K., Dirksen C.L., Palermo D.R., Suarez C.S., Kelly J., Kentala J.T., Crane D.D. Laboratory studies of acute varicella and varicella immune status. Diagn. Microbiol. Infect. Dis. 10:1988;149-158.
2. Bortz, J., Lienert, G.A., Boehnke, K., 2000. Verteilungsfreie Methoden in der Biostatistik, Springer, Berlin.
3. Bühl, A., Zöfel, P., 2003. SPSS11 - Einführung in die Moderne Datenanalyse unter Windows, Pearson Studium, München.
4. Coffin S.E., Hodinka R.L. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J. Clin. Microbiol. 33:1995;2792-2795.
5. Fong C.K., Landry M.L. Advantages of multiple cell culture systems for the detection of mixed-virus infections. J. Virol. Methods. 33:1991;283-289.
6. Gallagher J., Quaid B., Cryan B. Susceptibility to varicella zoster virus infection in health care workers. Occup. Med. 46:1996;289-292.
7. Gershon A.A., Raker R., Steinberg S., Topf-Olstein B., Drusin L.M. Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life. Pediatrics. 58:1976;692-696.
8. Gleaves C.A., Rice D.H., Meyers J.D. Use of serum substitutes for the growth of four cell lines commonly used for virus isolation. J. Virol. Methods. 28:1990;171-178.
9. Hayward A.R., Zerbe G.O., Levin M.J. Clinical application of responder cell frequency estimates with four years of follow up. J. Immunol. Methods. 170:1994;27-36.
10. Huang Y.T., Hite S., Duane V., Yan H. CV-1 and MRC-5 mixed cells for simultaneous detection of herpes simplex viruses and varicella-zoster virus in skin lesions. J. Clin. Virol. 24:2002;37-43.
11. Klevjer-Anderson P., Anderson L.W. Comparison of a new latex agglutination assay with indirect immunofluorescence to detect varicella-zoster antibodies. Diagn. Microbiol. Infect. Dis. 17:1993;247-249.
12. Krah D.L. Assays for antibodies to varicella-zoster virus. Infect. Dis. Clin. North Am. 10:1996;507-527.
13. Landry M.L., Cohen S.D., Mayo D.R., Fong C.K.J., Andiman W.A. Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus. J. Clin. Microbiol. 25:1987;832-835.
14. LaRussa P., Steinberg S., Waithe E., Hanna B., Holzman R. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody- to-membrane-antigen test. J. Clin. Microbiol. 25:1987;2059-2062.
15. Litwin V., Jackson W., Grose C. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J. Virol. 66:1992;3643-3651.
16. Morales-Castillo M.E., Alvarez-Munoz M.T., Solorzano-Santos F., Gonzalez-Robledo R., Jasso-Gutierrez L., Munoz-Hernandez O. Live varicella vaccine in both immunocompromised and healthy children. Arch. Med. Res. 31:2000;85-87.
17. National Institute for Biological Standards and Control, 2001. British Standard for varicella-zoster antibodies (NIBSC code 90/690). Instructions for use. Version 30 July, initial version.
18. Ndumbe P.M., Cradock-Watson J., Levinsky R.J. Natural and artificial immunity to varicella zoster virus. J. Med. Virol. 25:1988;171-178.
19. Paryani S.G., Arvin A.M., Koropchak C.M., Dobkin M.B., Wittek A.E., Amylon M.D., Budinger M.D. Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin. J. Pediatr. 105:1984;200-205.
20. Saiman L., LaRussa P., Steinberg S.P., Zhou J., Baron K., Whittier S., Della-Latta P., Gershon A.A. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers. Infect. Control Hosp. Epidemiol. 22:2001;279-283.
21. Salleras L., Dominguez A., Vidal J., Plans P., Salleras M., Taberner J.L. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine. 19:2000;183-188.
22. Sauerbrei A., Eichhorn U., Hottenrott G., Wutzler P. Virological diagnosis of herpes simplex encephalitis. J. Clin. Virol. 17:2000;31-36.
23. Sauerbrei A., Eichhorn U., Schacke M., Wutzler P. Laboratory diagnosis of herpes zoster. J. Clin. Virol. 14:1999;31-36.
24. Sauerbrei A., Wutzler P. The congenital varicella syndrome. J. Perinatol. 20:2000;548-554.
25. Smith C.D., Craft D.W., Shiromoto R.S., Po Y. Alternative cell line for virus isolation. J. Clin. Microbiol. 24:1986;265-268.
26. Thiry N., Beutels P., Shkedy Z., Vranckx R., Vandermeulen C., Van der Wielen M., Van Damme P. The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur. J. Pediatr. 161:2002;588-593.
27. Vandermissen G., Moens G., Vranckx R., de Schryver A., Jacques P. Occupational risk of infection by varicella-zoster virus in Belgian healthcare workers: a seroprevalence study. Occup. Environ. Med. 57:2000;621-626.
28. Walpita P., Darougar S., Marsh R.J., Cooper M. Development of an immunofluorescence test for the serodiagnosis of herpes zoster ophthalmicus. Br. J. Ophthalmol. 70:1986;431-434.
29. Wasmuth E.H., Miller W. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J. Med. Virol. 32:1990;189-193.
30. Weinberg A., Hayward A.R., Masters H.B., Ogu I.A., Levin M.J. Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity. J. Clin. Microbiol. 34:1996;445-446.
31. Williams V., Gershon A., Brunell P.A. Serologic response to varicella-zoster membrane antigens measured by immunofluorescence. J. Infect. Dis. 130:1974;669-672.
32. Wutzler P., Färber I., Wagenpfeil S., Bisanz H., Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine. 21:2002;121-124.
33. Zaia J.A., Oxman M.N. Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J. Infect. Dis. 156:1977;519-530.